AETHLON MEDICAL INC Income Statement
AEMD|12 years of annual SEC 10-K data (FY2011-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
Revenue has declined at a 7.5% compound annual rate over the past 11 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $0 | $574.2K | $650.2K | $229.6K | $229.6K | $886.6K | $392.1K | $1.6M | $1.2M | $1.4M | $1.4M |
| SG&A Expense | $3.2M | $3.9M | $4.5M | $1.5M | $953.5K | $953.5K | $929.0K | $849.5K | $931.1K | $746.1K | $852.6K | $852.6K |
| R&D Expense | $2.2M | $2.5M | $2.7M | $927.0K | $896.0K | $896.0K | $782.0K | $673.0K | $1.5M | $1.4M | - | - |
| Operating Income | -$9.3M | -$12.6M | -$11.9M | -$5.9M | -$6.0M | -$6.0M | -$4.4M | -$6.1M | -$3.1M | -$3.6M | -$3.1M | -$3.1M |
| Interest Expense | $10.1K | - | - | - | - | - | - | - | $1.3M | $59.9K | - | - |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - |
| Net Income | -$13.4M | -$12.2M | -$12.0M | -$6.4M | -$6.2M | -$6.2M | -$4.9M | -$7.3M | -$13.4M | -$4.9M | -$8.1M | -$8.1M |
| EPS (Basic) | -$5.86 | -$0.71 | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$5.86 | -$0.71 | - | -$1.87 | -$5.13 | -$0.10 | -$0.66 | -$1.22 | -$3.44 | -$0.03 | -$0.08 | -$0.08 |
| Shares Outstanding | 2.3M | 15.4M | 12.2M | 9.4M | 1.3M | 17.7M | 7.6M | 6.7M | 4.5M | 173.7M | 117.5M | 77.5M |
| Operating Margin | - | - | -2072.1% | -912.0% | -2612.5% | -2612.5% | -494.6% | -1555.4% | -188.2% | -290.7% | -229.1% | -229.1% |
| Profit Margin | - | - | -2094.9% | -980.3% | -2697.8% | -2697.8% | -549.6% | -1855.8% | -822.6% | -397.7% | -596.6% | -596.6% |